# A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement

Study · id `cardio:ct-nct05436028` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05436028](<https://clinicaltrials.gov/study/NCT05436028>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05436028

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 161 participants.

## Technical summary

Registry record NCT05436028. Allocation not applicable; no masking; primary purpose treatment. Start 2023-05-23 (actual); primary completion 2024-11-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 161 participants (enrolled count; ClinicalTrials.gov record NCT05436028, source copy `cardio:ctgov-nct05436028-2025-05-21`, retrieved 2026-10-26)
- Started: 2023-05-23 (actual) (ClinicalTrials.gov record NCT05436028, source copy `cardio:ctgov-nct05436028-2025-05-21`, retrieved 2026-10-26)
- Primary completion: 2024-11-30 (actual) (ClinicalTrials.gov record NCT05436028, source copy `cardio:ctgov-nct05436028-2025-05-21`, retrieved 2026-10-26)
- Completion: 2024-11-30 (actual) (ClinicalTrials.gov record NCT05436028, source copy `cardio:ctgov-nct05436028-2025-05-21`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT05436028, source copy `cardio:ctgov-nct05436028-2025-05-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05436028-2025-05-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement
- Condition: Tricuspid Regurgitation
- Intervention (Device): Transcatheter Tricuspid Valve Intervention
- Lead sponsor: Jenscare Scientific
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Tricuspid regurgitation (`cardio:tricuspid-regurgitation`)
- Registry lists this organization as the lead sponsor: Jenscare Scientific (`cardio:org-jenscare-scientific`)

## Provenance

Content hash: c02f7506665f74538fce70b65403e9dac84e257bec24a7f139d566a755411eab
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
